世界のアルファサラセミア市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alpha Thalassemia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0258
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、アルファサラセミアのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鉄キレート剤、遺伝子治療）、用途別市場規模（病院、私立クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・アルファサラセミアの市場動向
・企業の競争状況、市場シェア
・アルファサラセミアの種類別市場規模（鉄キレート剤、遺伝子治療）
・アルファサラセミアの用途別市場規模（病院、私立クリニック、その他）
・アルファサラセミアの北米市場規模2016-2027（アメリカ、カナダ）
・アルファサラセミアのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・アルファサラセミアのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アルファサラセミアの中南米市場規模2016-2027（メキシコ、ブラジル）
・アルファサラセミアの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bluebird Bio、Novartis、Kiadis Pharma、Acceleron Pharma）
・結論

Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.

Market Analysis and Insights: Global Alpha Thalassemia Market
The global Alpha Thalassemia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alpha Thalassemia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alpha Thalassemia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alpha Thalassemia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alpha Thalassemia market.

Global Alpha Thalassemia Scope and Market Size
Alpha Thalassemia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha Thalassemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Iron Chelating Drugs
Gene Therapy

Segment by Application
Hospitals
Private clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bluebird Bio
Novartis
Kiadis Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Thalassemia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Iron Chelating Drugs
1.2.3 Gene Therapy
1.3 Market by Application
1.3.1 Global Alpha Thalassemia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alpha Thalassemia Market Perspective (2016-2027)
2.2 Alpha Thalassemia Growth Trends by Regions
2.2.1 Alpha Thalassemia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alpha Thalassemia Historic Market Share by Regions (2016-2021)
2.2.3 Alpha Thalassemia Forecasted Market Size by Regions (2022-2027)
2.3 Alpha Thalassemia Industry Dynamic
2.3.1 Alpha Thalassemia Market Trends
2.3.2 Alpha Thalassemia Market Drivers
2.3.3 Alpha Thalassemia Market Challenges
2.3.4 Alpha Thalassemia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alpha Thalassemia Players by Revenue
3.1.1 Global Top Alpha Thalassemia Players by Revenue (2016-2021)
3.1.2 Global Alpha Thalassemia Revenue Market Share by Players (2016-2021)
3.2 Global Alpha Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alpha Thalassemia Revenue
3.4 Global Alpha Thalassemia Market Concentration Ratio
3.4.1 Global Alpha Thalassemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Revenue in 2020
3.5 Alpha Thalassemia Key Players Head office and Area Served
3.6 Key Players Alpha Thalassemia Product Solution and Service
3.7 Date of Enter into Alpha Thalassemia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alpha Thalassemia Breakdown Data by Type
4.1 Global Alpha Thalassemia Historic Market Size by Type (2016-2021)
4.2 Global Alpha Thalassemia Forecasted Market Size by Type (2022-2027)

5 Alpha Thalassemia Breakdown Data by Application
5.1 Global Alpha Thalassemia Historic Market Size by Application (2016-2021)
5.2 Global Alpha Thalassemia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alpha Thalassemia Market Size (2016-2027)
6.2 North America Alpha Thalassemia Market Size by Type
6.2.1 North America Alpha Thalassemia Market Size by Type (2016-2021)
6.2.2 North America Alpha Thalassemia Market Size by Type (2022-2027)
6.2.3 North America Alpha Thalassemia Market Size by Type (2016-2027)
6.3 North America Alpha Thalassemia Market Size by Application
6.3.1 North America Alpha Thalassemia Market Size by Application (2016-2021)
6.3.2 North America Alpha Thalassemia Market Size by Application (2022-2027)
6.3.3 North America Alpha Thalassemia Market Size by Application (2016-2027)
6.4 North America Alpha Thalassemia Market Size by Country
6.4.1 North America Alpha Thalassemia Market Size by Country (2016-2021)
6.4.2 North America Alpha Thalassemia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alpha Thalassemia Market Size (2016-2027)
7.2 Europe Alpha Thalassemia Market Size by Type
7.2.1 Europe Alpha Thalassemia Market Size by Type (2016-2021)
7.2.2 Europe Alpha Thalassemia Market Size by Type (2022-2027)
7.2.3 Europe Alpha Thalassemia Market Size by Type (2016-2027)
7.3 Europe Alpha Thalassemia Market Size by Application
7.3.1 Europe Alpha Thalassemia Market Size by Application (2016-2021)
7.3.2 Europe Alpha Thalassemia Market Size by Application (2022-2027)
7.3.3 Europe Alpha Thalassemia Market Size by Application (2016-2027)
7.4 Europe Alpha Thalassemia Market Size by Country
7.4.1 Europe Alpha Thalassemia Market Size by Country (2016-2021)
7.4.2 Europe Alpha Thalassemia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alpha Thalassemia Market Size (2016-2027)
8.2 Asia-Pacific Alpha Thalassemia Market Size by Type
8.2.1 Asia-Pacific Alpha Thalassemia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alpha Thalassemia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alpha Thalassemia Market Size by Type (2016-2027)
8.3 Asia-Pacific Alpha Thalassemia Market Size by Application
8.3.1 Asia-Pacific Alpha Thalassemia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alpha Thalassemia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alpha Thalassemia Market Size by Application (2016-2027)
8.4 Asia-Pacific Alpha Thalassemia Market Size by Region
8.4.1 Asia-Pacific Alpha Thalassemia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alpha Thalassemia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alpha Thalassemia Market Size (2016-2027)
9.2 Latin America Alpha Thalassemia Market Size by Type
9.2.1 Latin America Alpha Thalassemia Market Size by Type (2016-2021)
9.2.2 Latin America Alpha Thalassemia Market Size by Type (2022-2027)
9.2.3 Latin America Alpha Thalassemia Market Size by Type (2016-2027)
9.3 Latin America Alpha Thalassemia Market Size by Application
9.3.1 Latin America Alpha Thalassemia Market Size by Application (2016-2021)
9.3.2 Latin America Alpha Thalassemia Market Size by Application (2022-2027)
9.3.3 Latin America Alpha Thalassemia Market Size by Application (2016-2027)
9.4 Latin America Alpha Thalassemia Market Size by Country
9.4.1 Latin America Alpha Thalassemia Market Size by Country (2016-2021)
9.4.2 Latin America Alpha Thalassemia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alpha Thalassemia Market Size (2016-2027)
10.2 Middle East & Africa Alpha Thalassemia Market Size by Type
10.2.1 Middle East & Africa Alpha Thalassemia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alpha Thalassemia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alpha Thalassemia Market Size by Type (2016-2027)
10.3 Middle East & Africa Alpha Thalassemia Market Size by Application
10.3.1 Middle East & Africa Alpha Thalassemia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alpha Thalassemia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alpha Thalassemia Market Size by Application (2016-2027)
10.4 Middle East & Africa Alpha Thalassemia Market Size by Country
10.4.1 Middle East & Africa Alpha Thalassemia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alpha Thalassemia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Alpha Thalassemia Introduction
11.1.4 Bluebird Bio Revenue in Alpha Thalassemia Business (2016-2021)
11.1.5 Bluebird Bio Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Alpha Thalassemia Introduction
11.2.4 Novartis Revenue in Alpha Thalassemia Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Kiadis Pharma
11.3.1 Kiadis Pharma Company Details
11.3.2 Kiadis Pharma Business Overview
11.3.3 Kiadis Pharma Alpha Thalassemia Introduction
11.3.4 Kiadis Pharma Revenue in Alpha Thalassemia Business (2016-2021)
11.3.5 Kiadis Pharma Recent Development
11.4 Acceleron Pharma
11.4.1 Acceleron Pharma Company Details
11.4.2 Acceleron Pharma Business Overview
11.4.3 Acceleron Pharma Alpha Thalassemia Introduction
11.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Business (2016-2021)
11.4.5 Acceleron Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alpha Thalassemia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Iron Chelating Drugs
Table 3. Key Players of Gene Therapy
Table 4. Global Alpha Thalassemia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Alpha Thalassemia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alpha Thalassemia Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Alpha Thalassemia Market Share by Regions (2016-2021)
Table 8. Global Alpha Thalassemia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Alpha Thalassemia Market Share by Regions (2022-2027)
Table 10. Alpha Thalassemia Market Trends
Table 11. Alpha Thalassemia Market Drivers
Table 12. Alpha Thalassemia Market Challenges
Table 13. Alpha Thalassemia Market Restraints
Table 14. Global Alpha Thalassemia Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Alpha Thalassemia Market Share by Players (2016-2021)
Table 16. Global Top Alpha Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia as of 2020)
Table 17. Ranking of Global Top Alpha Thalassemia Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Alpha Thalassemia Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Alpha Thalassemia Product Solution and Service
Table 21. Date of Enter into Alpha Thalassemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Alpha Thalassemia Revenue Market Share by Type (2016-2021)
Table 25. Global Alpha Thalassemia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Alpha Thalassemia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Alpha Thalassemia Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Alpha Thalassemia Revenue Market Share by Application (2016-2021)
Table 29. Global Alpha Thalassemia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Alpha Thalassemia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Alpha Thalassemia Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Alpha Thalassemia Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Alpha Thalassemia Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Alpha Thalassemia Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Alpha Thalassemia Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Alpha Thalassemia Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Alpha Thalassemia Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Alpha Thalassemia Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Alpha Thalassemia Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Alpha Thalassemia Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Alpha Thalassemia Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Alpha Thalassemia Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Alpha Thalassemia Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Alpha Thalassemia Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Alpha Thalassemia Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Alpha Thalassemia Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Alpha Thalassemia Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Alpha Thalassemia Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Alpha Thalassemia Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Alpha Thalassemia Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Alpha Thalassemia Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Alpha Thalassemia Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Alpha Thalassemia Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Alpha Thalassemia Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Alpha Thalassemia Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Alpha Thalassemia Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bluebird Bio Company Details
Table 62. Bluebird Bio Business Overview
Table 63. Bluebird Bio Alpha Thalassemia Product
Table 64. Bluebird Bio Revenue in Alpha Thalassemia Business (2016-2021) & (US$ Million)
Table 65. Bluebird Bio Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Alpha Thalassemia Product
Table 69. Novartis Revenue in Alpha Thalassemia Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Kiadis Pharma Company Details
Table 72. Kiadis Pharma Business Overview
Table 73. Kiadis Pharma Alpha Thalassemia Product
Table 74. Kiadis Pharma Revenue in Alpha Thalassemia Business (2016-2021) & (US$ Million)
Table 75. Kiadis Pharma Recent Development
Table 76. Acceleron Pharma Company Details
Table 77. Acceleron Pharma Business Overview
Table 78. Acceleron Pharma Alpha Thalassemia Product
Table 79. Acceleron Pharma Revenue in Alpha Thalassemia Business (2016-2021) & (US$ Million)
Table 80. Acceleron Pharma Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha Thalassemia Market Share by Type: 2020 VS 2027
Figure 2. Iron Chelating Drugs Features
Figure 3. Gene Therapy Features
Figure 4. Global Alpha Thalassemia Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Private clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Alpha Thalassemia Report Years Considered
Figure 9. Global Alpha Thalassemia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Alpha Thalassemia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Alpha Thalassemia Market Share by Regions: 2020 VS 2027
Figure 12. Global Alpha Thalassemia Market Share by Regions (2022-2027)
Figure 13. Global Alpha Thalassemia Market Share by Players in 2020
Figure 14. Global Top Alpha Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Alpha Thalassemia Revenue in 2020
Figure 16. Global Alpha Thalassemia Revenue Market Share by Type (2016-2021)
Figure 17. Global Alpha Thalassemia Revenue Market Share by Type (2022-2027)
Figure 18. North America Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Alpha Thalassemia Market Share by Type (2016-2027)
Figure 20. North America Alpha Thalassemia Market Share by Application (2016-2027)
Figure 21. North America Alpha Thalassemia Market Share by Country (2016-2027)
Figure 22. United States Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alpha Thalassemia Market Share by Type (2016-2027)
Figure 26. Europe Alpha Thalassemia Market Share by Application (2016-2027)
Figure 27. Europe Alpha Thalassemia Market Share by Country (2016-2027)
Figure 28. Germany Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alpha Thalassemia Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Alpha Thalassemia Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Alpha Thalassemia Market Share by Region (2016-2027)
Figure 38. China Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alpha Thalassemia Market Share by Type (2016-2027)
Figure 46. Latin America Alpha Thalassemia Market Share by Application (2016-2027)
Figure 47. Latin America Alpha Thalassemia Market Share by Country (2016-2027)
Figure 48. Mexico Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alpha Thalassemia Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Alpha Thalassemia Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Alpha Thalassemia Market Share by Country (2016-2027)
Figure 54. Turkey Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Alpha Thalassemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bluebird Bio Revenue Growth Rate in Alpha Thalassemia Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Alpha Thalassemia Business (2016-2021)
Figure 59. Kiadis Pharma Revenue Growth Rate in Alpha Thalassemia Business (2016-2021)
Figure 60. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界のαサラセミア市場 2021：企業別、地域別、種類・用途別

Global Alpha Thalassemia Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00722 2021年4月 104Pages
当調査資料では、αサラセミアのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。αサラセミアの種類別市場規模（鉄キレート薬、遺伝子治療）、用途別市場規模（病院、私立診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア...

世界のアルファマンノシドーシス治療市場規模・現状・予測（2021年-2027年）

Global Alpha Mannosidosis Treatments Market Size, Status and Forecast 2021-2027
QYR2104Z0257 2021年4月 92Pages
QYResearch社発行の本調査資料では、アルファマンノシドーシス治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（骨髄移植（BMT）、酵素補充療法（ERT））、用途別市場規模（病院、専門クリニック）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のアルファエミッター市場規模・現状・予測（2021年-2027年）

Global Alpha Emitters Market Size, Status and Forecast 2021-2027
QYR2104Z0256 2021年4月 92Pages
QYResearch社発行の本調査資料では、アルファエミッターのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（テルビウム（Tb-149）、アスタチン（At-211）、ビスマス（Bi-212）、アクチニウム（Ac-225）、ラジウム（Ra-223...

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

Global GMP Tumor Necrosis Factor Alpha Market Size, Status and Forecast 2021-2027
QYR2104Z2601 2021年4月 99Pages
QYResearch社発行の本調査資料では、GMP腫瘍壊死因子アルファのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（25μg、50μg、その他）、用途別市場規模（細胞/遺伝子治療、組織工学製品、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

世界のアルファ-フェトプロテイン（AFP）検査市場規模・現状・予測（2021年-2027年）

Global Alpha-Fetaprotein Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0259 2021年4月 131Pages
QYResearch社発行の本調査資料では、アルファ-フェトプロテイン（AFP）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、分子診断、染色体分析、その他）、用途別市場規模（研究センター、病院、クリニック、その他）、主要地...

世界のアルファ-フェトプロテイン（AFP）検査市場規模・現状・予測（2021年-2027年）

世界のアルファ-アンチトリプシン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0255 2021年4月 133Pages
QYResearch社発行の本調査資料では、アルファ-アンチトリプシン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CT-2009、POL-6014、ARO-AAT、ALNAAT-02、その他）、用途別市場規模（クリニック、病院、そ...

世界のサラセミア市場 2021：企業別、地域別、種類・用途別

Global Thalassemia Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z13741 2021年4月 104Pages
当調査資料では、サラセミアのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。サラセミアの種類別市場規模（鉄キレート剤、その他）、用途別市場規模（病院、診療所、研究所、実験室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

世界のUAVサブシステム市場規模・現状・予測（2021年-2027年）

Global UAV Subsystems Market Size, Status and Forecast 2021-2027
QYR2104Z5775 2021年4月 90Pages
QYResearch社発行の本調査資料では、UAVサブシステムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（地上管制システム（GCS）、車載コンピューター）、用途別市場規模（軍用無人航空機、民間無人航空機）、主要地域別市場規模（北米、アメリカ...

世界のαサラセミア市場 2021：企業別、地域別、種類・用途別 The Alpha Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
世界のサラセミア市場 2021：企業別、地域別、種類・用途別 The Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
世界のアルファマンノシドーシス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alpha Mannosidosis Treatments Market The global Alpha Mannosidosis Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界のアルファエミッター市場規模・現状・予測（2021年-2027年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…
世界のαマンノース症市場 2021：企業別、地域別、種類・用途別 The Alpha Mannosidosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…